MD vs LFST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 16, 2026

MD

57.1
AI Score
VS
MD Wins

LFST

53.7
AI Score

Investment Advisor Scores

MD

57score
Recommendation
HOLD

LFST

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MD LFST Winner
Net Income 29.57M -307.20M MD
Operating Income 41.66M -286.35M MD
ROE 3.4% -19.9% MD
ROA 1.4% -15.9% MD
Total Assets 2.07B 1.93B MD
Cash 205.78M 148.03M MD
Debt/Equity 0.70 0.10 LFST
Current Ratio 1.33 2.28 LFST

Relative Price Performance (Last 90 Days)

MD 1M: +1.4% · 3M: +17.8% LFST 1M: -8.3% · 3M: +38.4%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 57

RSI (14): 57.0 · Price: $26.51

LFST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.2 · Price: $10.48

Fundamentals Snapshot

Metric MD LFST
Market Cap
Forward P/E 11.3 26.7
Trailing P/E 12.7 179.0
Revenue (TTM)
Revenue Growth 0.0% 0.2%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 2.12 0.06
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.